2015-Nowadays (Side projects)
Other publications


  1. How chronic is polypharmacy in old age? A longitudinal nationwide cohort study, Wastesson, J. W.; Morin, L.; Laroche, M.-L.; Johnell, K., Journal of the American Geriatrics Society 2019, 67, 455-462, http://doi.org/10.1111/jgs.15717
  2. Towards a generic tool for prediction of meropenem systemic and infection-site exposure: A physiologically based pharmacokinetic model for adult patients with pneumonia, Thémans, P.; Marquet, P.; Winkin, J. J.; Musuamba, F. T., Drugs in R&D 2019, 19, 177-189, http://doi.org/10.1007/s40268-019-0268-x
  3. The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey, Sirois, C.; Lunghi, C.; Laroche, M.-L.; Maheux, A.; Frini, A., Research in social & administrative pharmacy: RSAP 2019, 15, 761-766, http://doi.org/10.1016/j.sapharm.2018.09.008
  4. Glomerular hyper- and hypofiltration during acute circulatory failure: Iohexol-based gold-standard descriptive study, Salmon Gandonnière, C.; Helms, J.; Le Tilly, O.; Benz-de Bretagne, I.; Bretagnol, A.; Bodet-Contentin, L.; Mercier, E.; Halimi, J.-M., et al., Critical Care Medicine 2019, 47, e623-e629, http://doi.org/10.1097/CCM.0000000000003804
  5. Adverse events associated with currently used medical treatments for cystinuria and treatment goals: Results from a series of 442 patients in france, Prot-Bertoye, C.; Lebbah, S.; Daudon, M.; Tostivint, I.; Jais, J.-P.; Lillo-Le Louët, A.; Pontoizeau, C.; Cochat, P., et al., BJU international 2019, http://doi.org/10.1111/bju.14721
  6. Autotransplantation of cryoconserved ovarian tissue: First experience in universitary hospital center of lille, Pouypoudat, L.; Vinatier, D.; Keller, L.; Decanter, C.; Leroy-Martin, B.; Piver, P.; Collinet, P., Gynecologie, Obstetrique, Fertilite & Senologie 2019, http://doi.org/10.1016/j.gofs.2019.08.002
  7. Middle-molecule uremic toxins: A renewed interest, Nlandu, Y.; Padden, M.; Seidowsky, A.; Hamaz, S.; Vilaine, É.; Cheddani, L.; Essig, M.; Massy, Z. A., Nephrologie & Therapeutique 2019, 15, 82-90, http://doi.org/10.1016/j.nephro.2018.09.003
  8. How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study, Morin, L.; Wastesson, J. W.; Laroche, M.-L.; Fastbom, J.; Johnell, K., Palliative Medicine 2019, 33, 1080-1090, http://doi.org/10.1177/0269216319854013
  9. Direct-acting antivirals in hepatitis c virus-associated diffuse large b-cell lymphomas, Merli, M.; Frigeni, M.; Alric, L.; Visco, C.; Besson, C.; Mannelli, L.; Di Rocco, A.; Ferrari, A., et al., The Oncologist 2019, 24, e720-e729, http://doi.org/10.1634/theoncologist.2018-0331
  10. In vitro survival of follicles in prepubertal ewe ovarian cortex cryopreserved by slow freezing or non-equilibrium vitrification, Locatelli, Y.; Calais, L.; Duffard, N.; Lardic, L.; Monniaux, D.; Piver, P.; Mermillod, P.; Bertoldo, M. J., Journal of Assisted Reproduction and Genetics 2019, http://doi.org/10.1007/s10815-019-01532-8
  11. Para-aortic lymph node invasion in high-risk endometrial cancer: Performance of 18fdg pet-ct, Legros, M.; Margueritte, F.; Tardieu, A.; Deluche, E.; Mbou, V. B.; Lacorre, A.; Ceuca, A.; Aubard, Y., et al., Anticancer Research 2019, 39, 619-625, http://doi.org/10.21873/anticanres.13155
  12. Safety and efficacy of the combination simeprevir-sofosbuvir in hcv genotype 1- and 4-mono-infected patients from the french anrs co22 hepather cohort, Laurain, A.; Metivier, S.; Haour, G.; Larrey, D.; Dorival, C.; Hezode, C.; Zoulim, F.; Marcellin, P., et al., BMC infectious diseases 2019, 19, 300, http://doi.org/10.1186/s12879-019-3923-5
  13. Lignin modification supported by dft-based theoretical study as a way to produce competitive natural antioxidants, Lauberte, L.; Fabre, G.; Ponomarenko, J.; Dizhbite, T.; Evtuguin, D. V.; Telysheva, G.; Trouillas, P., Molecules (Basel, Switzerland) 2019, 24, http://doi.org/10.3390/molecules24091794
  14. Pharmacoepidemiology in older people: Purposes and future directions, Laroche, M.-L.; Sirois, C.; Reeve, E.; Gnjidic, D.; Morin, L., Therapie 2019, 74, 325-332, http://doi.org/10.1016/j.therap.2018.10.006
  15. Arginine vasopressin and posterior reversible encephalopathy syndrome pathophysiology: The missing link?, Largeau, B.; Le Tilly, O.; Sautenet, B.; Salmon Gandonnière, C.; Barin-Le Guellec, C.; Ehrmann, S., Molecular Neurobiology 2019, http://doi.org/10.1007/s12035-019-1553-y
  16. Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma, Jouve, J.-L.; Lecomte, T.; Bouché, O.; Barbier, E.; Khemissa Akouz, F.; Riachi, G.; Nguyen Khac, E.; Ollivier-Hourmand, I., et al., Journal of Hepatology 2019, 71, 516-522, http://doi.org/10.1016/j.jhep.2019.04.021
  17. Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: Prospective trial with assessment of pyloric function, Jacques, J.; Pagnon, L.; Hure, F.; Legros, R.; Crepin, S.; Fauchais, A.-L.; Palat, S.; Ducrotté, P., et al., Endoscopy 2019, 51, 40-49, http://doi.org/10.1055/a-0628-6639
  18. Evaluation of a non-parametric modelling for meropenem in critically ill patients using monte carlo simulation, Idoate Grijalba, A. I.; Aldaz Pastor, A.; Marquet, P.; Woillard, J.-B., European Journal of Clinical Pharmacology 2019, http://doi.org/10.1007/s00228-019-02716-y
  19. Redox properties of individual quercetin moieties, Heřmánková, E.; Zatloukalová, M.; Biler, M.; Sokolová, R.; Bancířová, M.; Tzakos, A. G.; Křen, V.; Kuzma, M., et al., Free Radical Biology & Medicine 2019, http://doi.org/10.1016/j.freeradbiomed.2019.08.001
  20. Pharmacogenetics biomarkers predictive of drug pharmacodynamics as an additional tool to therapeutic drug monitoring, Haufroid, V.; Picard, N., Therapeutic Drug Monitoring 2019, 41, 121-130, http://doi.org/10.1097/FTD.0000000000000591
  21. Influence of hemodialysis on pramipexole pharmacokinetics: Lessons from two cases and literature review, Hanset, N.; Hantson, P.; Saint-Marcoux, F.; Devresse, A.; Jadoul, M.; Labriola, L., Clinical Nephrology. Case Studies 2019, 7, 11-16, http://doi.org/10.5414/CNCS109641
  22. Accreditation of the toxicological screening: Recommendations of the sfbc-sfta group, Guitton, J.; Gaulier, J.-M.; Citterio-Quentin, A.; Abe, E.; Allibé, N.; Bartoli, M.; Cohen, S.; Monteil-Ganiere, C., et al., Annales De Biologie Clinique 2019, 77, 219-224, http://doi.org/10.1684/abc.2019.1422
  23. Self-poisoning with 60 tablets of apixaban, a pharmacokinetics case report, Franck, B.; Dulaurent, S.; El Balkhi, S.; Monchaud, C.; Picard, N.; Couderc, S.; Marquet, P.; Saint-Marcoux, F., et al., British Journal of Clinical Pharmacology 2019, 85, 270-272, http://doi.org/10.1111/bcp.13790
  24. Impairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting o-acetyl gd2 ganglioside, Fleurence, J.; Bahri, M.; Fougeray, S.; Faraj, S.; Vermeulen, S.; Pinault, E.; Geraldo, F.; Oliver, L., et al., International Journal of Cancer 2019, http://doi.org/10.1002/ijc.32533
  25. Antioxidant-inspired drug discovery: Antitumor metabolite is formed in situ from a hydroxycinnamic acid derivative upon free-radical scavenging, Fási, L.; Di Meo, F.; Kuo, C.-Y.; Stojkovic Buric, S.; Martins, A.; Kúsz, N.; Béni, Z.; Dékány, M., et al., Journal of Medicinal Chemistry 2019, 62, 1657-1668, http://doi.org/10.1021/acs.jmedchem.8b01994
  26. What is the cost of endoscopic submucosal dissection (esd)? A medico-economic study, Dahan, M.; Pauliat, E.; Liva-Yonnet, S.; Brischoux, S.; Legros, R.; Tailleur, A.; Carrier, P.; Charissoux, A., et al., United European Gastroenterology Journal 2019, 7, 138-145, http://doi.org/10.1177/2050640618810572
  27. Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder, Couffignal, C.; Bertrand, J.; Sportiche, S.; Jarroir, M.; El Balkhi, S.; Djebrani-Oussedik, N.; Poupon, J.; Declèves, X., et al., European Journal of Clinical Pharmacology 2019, 75, 519-528, http://doi.org/10.1007/s00228-018-2605-3
  28. The european association for clinical pharmacology and therapeutics-25 years’ young and going strong, Coleman, J. J.; Samer, C.; Zeitlinger, M.; van Agtmael, M.; Rongen, G. A.; Marquet, P.; Simon, T.; Singer, D., et al., European Journal of Clinical Pharmacology 2019, 75, 743-750, http://doi.org/10.1007/s00228-019-02690-5
  29. Clinical outcomes in patients with chronic hepatitis c after direct-acting antiviral treatment: A prospective cohort study, Carrat, F.; Fontaine, H.; Dorival, C.; Simony, M.; Diallo, A.; Hezode, C.; De Ledinghen, V.; Larrey, D., et al., Lancet (London, England) 2019, 393, 1453-1464, http://doi.org/10.1016/S0140-6736(18)32111-1
  30. Tuning optical properties of chalcone derivatives: A computational study, Bayach, I.; D’Aleó, A.; Trouillas, P., The Journal of Physical Chemistry. A 2019, 123, 194-201, http://doi.org/10.1021/acs.jpca.8b08529
  31. A study of the association between ugt1a1*28 variant allele of ugt1a1 gene and colonic phenotype of sporadic colorectal cancer, Anon, B.; Perray, C.; Regnault, D.; Caulet, M.; Orain, I.; Godart, B.; Pages, J.-C.; Tallet, A., et al., Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019, 51, 579-583, http://doi.org/10.1016/j.dld.2018.11.032
  32. Hepatitis b virus blocks the cre/creb complex and prevents tlr9 transcription and function in human b cells, Tout, I.; Gomes, M.; Ainouze, M.; Marotel, M.; Pecoul, T.; Durantel, D.; Vaccarella, S.; Dubois, B., et al., Journal of Immunology (Baltimore, Md.: 1950) 2018, 201, 2331-2344, http://doi.org/10.4049/jimmunol.1701726
  33. Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: A case report, Thomas, F.; Veal, G. J.; El Balkhi, S.; Lafont, T.; Picard, N.; Brugières, L.; Chatelut, E.; Piguet, C., Cancer Chemotherapy and Pharmacology 2018, 82, 361-365, http://doi.org/10.1007/s00280-018-3625-5
  34. Diagnosis accuracy of endoscopy (laparoscopy, hysteroscopy, fertiloscopy, cystoscopy, colonoscopy) in case of endometriosis: Cngof-has endometriosis guidelines, Tardieu, A.; Sire, F.; Gauthier, T., Gynecologie, Obstetrique, Fertilite & Senologie 2018, 46, 200-208, http://doi.org/10.1016/j.gofs.2018.02.024
  35. Risk of axillary recurrence after sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer, Tardieu, A.; Mesnard, C.; Margueritte, F.; Mollard, J.; Lacorre, A.; Aubard, Y.; Deluche, E.; Gauthier, T., Gynecologie, Obstetrique, Fertilite & Senologie 2018, 46, 509-513, http://doi.org/10.1016/j.gofs.2018.05.002
  36. Lipid bilayer position and orientation of novel carprofens, modulators of γ-secretase in alzheimer’s disease, Salnikov, E.; Drung, B.; Fabre, G.; Itkin, A.; Otyepka, M.; Dencher, N. A.; Schmidt, B.; Hauß, T., et al., Biochimica Et Biophysica Acta. Biomembranes 2018, 1860, 2224-2233, http://doi.org/10.1016/j.bbamem.2018.09.003
  37. Binding modes and selectivity of ruthenium complexes to human telomeric DNA g-quadruplexes, Rubio-Magnieto, J.; Kajouj, S.; Di Meo, F.; Fossépré, M.; Trouillas, P.; Norman, P.; Linares, M.; Moucheron, C., et al., Chemistry (Weinheim an Der Bergstrasse, Germany) 2018, 24, 15577-15588, http://doi.org/10.1002/chem.201802147
  38. Sk3 gene polymorphism is associated with taxane neurotoxicity and cell calcium homeostasis, Rua, C.; Guéguinou, M.; Soubai, I.; Viel, E.; Potier-Cartereau, M.; Chantome, A.; Barbe, C.; Bougnoux, P., et al., Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2018, 24, 5313-5320, http://doi.org/10.1158/1078-0432.CCR-18-0870
  39. Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis c virus genotype 4: The anrs hc32 quattro study, Roulot, D.; Thibault, V.; Laforest, C.; Fontaine, H.; Bronowicki, J.-P.; Asselah, T.; Bourlière, M.; Canva, V., et al., European Journal of Gastroenterology & Hepatology 2018, 30, 302-309, http://doi.org/10.1097/MEG.0000000000001035
  40. Fully automated sample preparation procedure to measure drugs of abuse in plasma by liquid chromatography tandem mass spectrometry, Robin, T.; Barnes, A.; Dulaurent, S.; Loftus, N.; Baumgarten, S.; Moreau, S.; Marquet, P.; El Balkhi, S., et al., Analytical and Bioanalytical Chemistry 2018, 410, 5071-5083, http://doi.org/10.1007/s00216-018-1159-7
  41. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: A european expert consensus, Morin, L.; Laroche, M.-L.; Vetrano, D. L.; Fastbom, J.; Johnell, K., European Journal of Clinical Pharmacology 2018, 74, 1333-1342, http://doi.org/10.1007/s00228-018-2507-4
  42. The epidemiology of polypharmacy in older adults: Register-based prospective cohort study, Morin, L.; Johnell, K.; Laroche, M.-L.; Fastbom, J.; Wastesson, J. W., Clinical Epidemiology 2018, 10, 289-298, http://doi.org/10.2147/CLEP.S153458
  43. Endogenous metabolites-mediated communication between oat1/oat3 and oatp1b1 may explain the association between slco1b1 snps and methotrexate toxicity, Martinez, D.; Muhrez, K.; Woillard, J.-B.; Berthelot, A.; Gyan, E.; Choquet, S.; Andrès, C. R.; Marquet, P., et al., Clinical Pharmacology and Therapeutics 2018, 104, 687-698, http://doi.org/10.1002/cpt.1008
  44. How i do… sacrospinofixation following richter technique by mini-invasive vaginal route, Margueritte, F.; Sallée, C.; Aubard, Y.; Gauthier, T., Gynecologie, Obstetrique, Fertilite & Senologie 2018, 46, 130-132, http://doi.org/10.1016/j.gofs.2017.12.003
  45. European association for the study of the liver and french hepatitis c recent guidelines: The paradigm shift, Loustaud-Ratti, V.; Debette-Gratien, M.; Carrier, P., World Journal of Hepatology 2018, 10, 639-644, http://doi.org/10.4254/wjh.v10.i10.639
  46. Dihydropyrimidine déhydrogenase (dpd) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the french gpco-unicancer and rnpgx networks, Loriot, M.-A.; Ciccolini, J.; Thomas, F.; Barin-Le-Guellec, C.; Royer, B.; Milano, G.; Picard, N.; Becquemont, L., et al., Bulletin Du Cancer 2018, 105, 397-407, http://doi.org/10.1016/j.bulcan.2018.02.001
  47. Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients, Leger, D. Y.; Moreau, S.; Signol, N.; Fargeas, J.-B.; Picat, M.-A.; Penot, A.; Abraham, J.; Laroche, M.-L., et al., Journal of Geriatric Oncology 2018, 9, 60-67, http://doi.org/10.1016/j.jgo.2017.07.015
  48. Misuse and adverse effects of new direct oral anticoagulants: A prospective observational study in patients admitted to an emergency unit of a french university hospital, Lafon, T.; Vallejo, C.; Hadj, M.; Laroche, M.-L.; Geniaux, H., Therapie 2018, 73, 209-215, http://doi.org/10.1016/j.therap.2017.05.004
  49. High-throughput monitoring of cocaine and its metabolites in hair using microarrays for mass spectrometry and matrix-assisted laser desorption/ionization-tandem mass spectrometry, Kernalléguen, A.; Steinhoff, R.; Bachler, S.; Dittrich, P. S.; Saint-Marcoux, F.; El Bakhi, S.; Vorspan, F.; Léonetti, G., et al., Analytical Chemistry 2018, 90, 2302-2309, http://doi.org/10.1021/acs.analchem.7b04693
  50. Removal of large colorectal lesions resected by endoscopic submucosal dissection using a laparoscopic bag, Jacques, J.; Taibi, A.; Charrissoux, A.; Pioche, M.; Carrier, P.; Chaput, B.; Legros, R., Endoscopy 2018, 50, E1-E2, http://doi.org/10.1055/s-0043-119977
  51. Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the serc trial: Axillary dissection versus no axillary dissection in patients with involved sentinel node, Houvenaeghel, G.; Cohen, M.; Raro, P.; De Troyer, J.; de Lara, C. T.; Gimbergues, P.; Gauthier, T.; Faure-Virelizier, C., et al., BMC cancer 2018, 18, 1153, http://doi.org/10.1186/s12885-018-5053-7
  52. 12 weeks of a ribavirin-free sofosbuvir and nonstructural protein 5a inhibitor regimen is enough to treat recurrence of hepatitis c after liver transplantation, Houssel-Debry, P.; Coilly, A.; Fougerou-Leurent, C.; Jezequel, C.; Duvoux, C.; De Ledinghen, V.; Radenne, S.; Kamar, N., et al., Hepatology (Baltimore, Md.) 2018, 68, 1277-1287, http://doi.org/10.1002/hep.29918
  53. Prophylactic cefazolin concentrations in morbidly obese patients undergoing sleeve gastrectomy: Do we achieve targets?, Grégoire, M.; Dumont, R.; Ronchi, L.; Woillard, J.-B.; Atthar, V.; Letessier, E.; Cinotti, R.; Roquilly, A., et al., International Journal of Antimicrobial Agents 2018, 52, 28-34, http://doi.org/10.1016/j.ijantimicag.2018.02.015
  54. Gastroparesis may be the cause of unexplained dyspepsia in patients with primary sjögren syndrome, Geyl, S.; Jacques, J.; Parreau, S.; Cypierre, A.; Tabouret, T.; Gondran, G.; Ly, K. H.; Liozon, E., et al., La Revue De Medecine Interne 2018, 39, 427-430, http://doi.org/10.1016/j.revmed.2018.02.007
  55. Antibiotic-loaded porous alumina ceramic for one-stage surgery for chronic osteomyelitis, Fiorenza, F.; Durox, H.; El Balkhi, S.; Denes, E., Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews 2018, 2, e079, http://doi.org/10.5435/JAAOSGlobal-D-18-00079
  56. Epidemiology and diagnosis strategy: Cngof-has endometriosis guidelines, Fauconnier, A.; Borghese, B.; Huchon, C.; Thomassin-Naggara, I.; Philip, C.-A.; Gauthier, T.; Bourdel, N.; Denouel, A., et al., Gynecologie, Obstetrique, Fertilite & Senologie 2018, 46, 223-230, http://doi.org/10.1016/j.gofs.2018.02.012
  57. Pristinamycin-induced arthralgia and myalgia: Analysis of the french pharmacovigilance database, Denis Prevot, M.; Thillard, E. M.; Walther, J.; Veyrac, G.; Laroche, M. L.; Gautier, S.; Auffret, M., Medecine Et Maladies Infectieuses 2018, 48, 58-62, http://doi.org/10.1016/j.medmal.2017.09.014
  58. Fetal supraventricular tachycardia and cystic fibrosis: Coincidence or association? Two case reports, Coste Mazeau, P.; Aubard, Y.; Aubard, V.; Martin, S.; Bejjani, L.; Yardin, C., Journal of Gynecology Obstetrics and Human Reproduction 2018, 47, 409-411, http://doi.org/10.1016/j.jogoh.2018.05.009
  59. A placebo-controlled trial of bezafibrate in primary biliary cholangitis, Corpechot, C.; Chazouillères, O.; Rousseau, A.; Le Gruyer, A.; Habersetzer, F.; Mathurin, P.; Goria, O.; Potier, P., et al., The New England Journal of Medicine 2018, 378, 2171-2181, http://doi.org/10.1056/NEJMoa1714519
  60. Management of endometriosis: Cngof/has clinical practice guidelines – short version, Collinet, P.; Fritel, X.; Revel-Delhom, C.; Ballester, M.; Bolze, P. A.; Borghese, B.; Bornsztein, N.; Boujenah, J., et al., Journal of Gynecology Obstetrics and Human Reproduction 2018, 47, 265-274, http://doi.org/10.1016/j.jogoh.2018.06.003
  61. Management of endometriosis: Cngof-has practice guidelines (short version), Collinet, P.; Fritel, X.; Revel-Delhom, C.; Ballester, M.; Bolze, P. A.; Borghese, B.; Bornsztein, N.; Boujenah, J., et al., Gynecologie, Obstetrique, Fertilite & Senologie 2018, 46, 144-155, http://doi.org/10.1016/j.gofs.2018.02.027
  62. Treating hepatic encephalopathy in cirrhotic patients admitted to icu with sodium phenylbutyrate: A preliminary study, Carrier, P.; Loustaud-Ratti, V., Fundamental & Clinical Pharmacology 2018, 32, 206-208, http://doi.org/10.1111/fcp.12353
  63. Beyond serum creatinine: Which tools to evaluate renal function in cirrhotic patients?, Carrier, P.; Debette-Gratien, M.; Essig, M.; Loustaud-Ratti, V., Hepatology Research: The Official Journal of the Japan Society of Hepatology 2018, 48, 771-779, http://doi.org/10.1111/hepr.13224
  64. Local low dose curcumin treatment improves functional recovery and remyelination in a rat model of sciatic nerve crush through inhibition of oxidative stress, Caillaud, M.; Chantemargue, B.; Richard, L.; Vignaud, L.; Favreau, F.; Faye, P.-A.; Vignoles, P.; Sturtz, F., et al., Neuropharmacology 2018, 139, 98-116, http://doi.org/10.1016/j.neuropharm.2018.07.001
  65. Nicorandil and cutaneous ulcerations, their misdiagnosis and consequences: Illustration by five cases reports and a review of the french pharmacovigilance database, Béné, J.; Carpentier, O.; Sabanowski, S.; Laroche, M.-L.; Beyens, M.-N.; Lambert, M.; Gautier, S.; Network, F. P., Therapie 2018, 73, 409-417, http://doi.org/10.1016/j.therap.2018.01.004
  66. Safety of sofosbuvir-based regimens after liver transplantation: Longitudinal assessment of renal function in the prospective anrs co23 cupilt study, Anty, R.; Favre, G.; Coilly, A.; Rossignol, E.; Houssel-Debry, P.; Duvoux, C.; De Ledinghen, V.; Di Martino, V., et al., Alimentary Pharmacology & Therapeutics 2018, 47, 1682-1689, http://doi.org/10.1111/apt.14639
  67. Possible association of cag repeat polymorphism in kcnn3 encoding the potassium channel sk3 with oxaliplatin-induced neurotoxicity, Anon, B.; Largeau, B.; Girault, A.; Chantome, A.; Caulet, M.; Perray, C.; Moussata, D.; Vandier, C., et al., Cancer Chemotherapy and Pharmacology 2018, 82, 149-157, http://doi.org/10.1007/s00280-018-3600-1
  68. Grazoprevir plus elbasvir in hcv genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective, Alric, L.; Ollivier-Hourmand, I.; Bérard, E.; Hillaire, S.; Guillaume, M.; Vallet-Pichard, A.; Bernard-Chabert, B.; Loustaud-Ratti, V., et al., Kidney International 2018, 94, 206-213, http://doi.org/10.1016/j.kint.2018.02.019
  69. A time-dependent model describes methotrexate elimination and supports dynamic modification of mrp2/abcc2 activity, Woillard, J.-B.; Debord, J.; Benz-de-Bretagne, I.; Saint-Marcoux, F.; Turlure, P.; Girault, S.; Abraham, J.; Choquet, S., et al., Therapeutic Drug Monitoring 2017, 39, 145-156, http://doi.org/10.1097/FTD.0000000000000381
  70. Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization, Vavříková, E.; Křen, V.; Jezova-Kalachova, L.; Biler, M.; Chantemargue, B.; Pyszková, M.; Riva, S.; Kuzma, M., et al., European Journal of Medicinal Chemistry 2017, 127, 263-274, http://doi.org/10.1016/j.ejmech.2016.12.051
  71. Polypharmacy in multimorbid older adults: Protocol for a systematic review, Sirois, C.; Laroche, M.-L.; Guénette, L.; Kröger, E.; Cooper, D.; Émond, V., Systematic Reviews 2017, 6, 104, http://doi.org/10.1186/s13643-017-0492-9
  72. Safety and efficacy of daclatasvir-sofosbuvir in hcv genotype 1-mono-infected patients, Pol, S.; Bourliere, M.; Lucier, S.; Hezode, C.; Dorival, C.; Larrey, D.; Bronowicki, J.-P.; Ledinghen, V. D. E., et al., Journal of Hepatology 2017, 66, 39-47, http://doi.org/10.1016/j.jhep.2016.08.021
  73. Traitements personnalisés grâce à la pharmacogénétique : Niveaux de preuve et de recommandations du réseau national de pharmacogénétique (rnpgx), Picard, N.; Boyer, J.-C.; Etienne-Grimaldi, M.-C.; Barin-Le Guellec, C.; Thomas, F.; Loriot, M.-A.; (RNPGx), R. n. d. p., Therapie 2017, 72, 175-183, http://doi.org/10.1016/j.therap.2016.09.007
  74. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the french network of pharmacogenetics (rnpgx), Picard, N.; Boyer, J.-C.; Etienne-Grimaldi, M.-C.; Barin-Le Guellec, C.; Thomas, F.; Loriot, M.-A.; (RNPGx), F. N. N. o. P., Therapie 2017, 72, 185-192, http://doi.org/10.1016/j.therap.2016.09.014
  75. Single nucleotide polymorphisms of abcc2 modulate renal secretion of endogenous organic anions, Muhrez, K.; Largeau, B.; Emond, P.; Montigny, F.; Halimi, J.-M.; Trouillas, P.; Barin-Le Guellec, C., Biochemical Pharmacology 2017, 140, 124-138, http://doi.org/10.1016/j.bcp.2017.05.012
  76. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients, Lainé, F.; Ruivard, M.; Loustaud-Ratti, V.; Bonnet, F.; Calès, P.; Bardou-Jacquet, E.; Sacher-Huvelin, S.; Causse, X., et al., Hepatology (Baltimore, Md.) 2017, 65, 465-474, http://doi.org/10.1002/hep.28856
  77. Gastric peroral endoscopic pyloromyotomy as a salvage therapy for refractory gastroparesis: A case series of different subtypes, Jacques, J.; Legros, R.; Monteil, J.; Loustaud-Ratti, V.; Sautereau, D., Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 2017, 29, http://doi.org/10.1111/nmo.12932
  78. Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: A case control study, Falkowski, S.; Woillard, J.-B.; Postil, D.; Tubiana-Mathieu, N.; Terrebonne, E.; Pariente, A.; Smith, D.; Guimbaud, R., et al., BMC cancer 2017, 17, 901, http://doi.org/10.1186/s12885-017-3728-0
  79. Role of the bridging group in bis-pyridyl ligands: Enhancing both the photo- and electroluminescent features of cationic (ipr)cui complexes, Elie, M.; Weber, M. D.; Di Meo, F.; Sguerra, F.; Lohier, J.-F.; Pansu, R. B.; Renaud, J.-L.; Hamel, M., et al., Chemistry (Weinheim an Der Bergstrasse, Germany) 2017, 23, 16328-16337, http://doi.org/10.1002/chem.201703270
  80. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer, El Balkhi, S.; Chaslot, M.; Picard, N.; Dulaurent, S.; Delage, M.; Mathieu, O.; Saint-Marcoux, F., International Journal of Legal Medicine 2017, 131, 979-988, http://doi.org/10.1007/s00414-017-1541-6
  81. Direct-acting antiviral agent-based regimen for hcv recurrence after combined liver-kidney transplantation: Results from the anrs co23 cupilt study, Dharancy, S.; Coilly, A.; Fougerou-Leurent, C.; Duvoux, C.; Kamar, N.; Leroy, V.; Tran, A.; Houssel-Debry, P., et al., American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017, 17, 2869-2878, http://doi.org/10.1111/ajt.14490
  82. Assessment of ki67 and upa/pai-1 expression in intermediate-risk early stage breast cancers, Deluche, E.; Venat-Bouvet, L.; Leobon, S.; Fermeaux, V.; Mollard, J.; Saidi, N.; Jammet, I.; Aubard, Y., et al., BMC cancer 2017, 17, 662, http://doi.org/10.1186/s12885-017-3648-z
  83. Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the oxytam study, Dalenc, F.; Iuliano, L.; Filleron, T.; Zerbinati, C.; Voisin, M.; Arellano, C.; Chatelut, E.; Marquet, P., et al., The Journal of Steroid Biochemistry and Molecular Biology 2017, 169, 210-218, http://doi.org/10.1016/j.jsbmb.2016.06.010
  84. Unsuccessful suicide attempt with tiapride, Couderc, S.; Mourou, H.; Monchaud, C.; Saint-Marcoux, F., Therapeutic Drug Monitoring 2017, 39, 581-583, http://doi.org/10.1097/FTD.0000000000000453
  85. Cervical ripening after previous cesarean section with dinoprostone vaginal insert, Coste Mazeau, P.; Catalan, C.; Eyraud, J.-L.; Aubard, Y.; Gauthier, T., Gynecologie, Obstetrique, Fertilite & Senologie 2017, 45, 77-82, http://doi.org/10.1016/j.gofs.2016.12.018
  86. Genetic analysis of mu and kappa opioid receptor and comt enzyme in cancer pain tunisian patients under opioid treatment, Chatti, I.; Woillard, J.-B.; Mili, A.; Creveaux, I.; Ben Charfeddine, I.; Feki, J.; Langlais, S.; Ben Fatma, L., et al., Iranian Journal of Public Health 2017, 46, 1704-1711,
  87. Liquid chromatography-mass spectrometry methods for the intracellular determination of drugs and their metabolites: A focus on antiviral drugs, Billat, P.-A.; Saint-Marcoux, F., Analytical and Bioanalytical Chemistry 2017, 409, 5837-5853, http://doi.org/10.1007/s00216-017-0449-9
  88. Editorial, Becquemont, L.; Picard, N.; Verstuyft, C., Therapie 2017, 72, 173-174, http://doi.org/10.1016/j.therap.2017.01.004
  89. Pregnancy and primary sjögren’s syndrome: Management and outcomes in a multicentre retrospective study of 54 pregnancies, Ballester, C.; Grobost, V.; Roblot, P.; Pourrat, O.; Pierre, F.; Laurichesse-Delmas, H.; Gallot, D.; Aubard, Y., et al., Scandinavian Journal of Rheumatology 2017, 46, 56-63, http://doi.org/10.3109/03009742.2016.1158312
  90. Pharmacokinetics-based adjusted versus standard dose of ribavirin does not improve virologic response rates in chronic hepatitis c genotype 4 patients: A randomized controlled trial, Altraif, I. H.; Sanai, F.; Babatin, M. A.; Alalwan, A. A.; Abdo, A. A.; Alhamoudi, W.; Peedikayil, M.; Alghamdi, H., et al., Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 2017, 37, 488-493, http://doi.org/10.1089/jir.2017.0054
  91. Role of iron in the pathogenesis of respiratory disease, Ali, M. K.; Kim, R. Y.; Karim, R.; Mayall, J. R.; Martin, K. L.; Shahandeh, A.; Abbasian, F.; Starkey, M. R., et al., The International Journal of Biochemistry & Cell Biology 2017, 88, 181-195, http://doi.org/10.1016/j.biocel.2017.05.003
  92. Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis c virus genotype 1 infection, Zeuzem, S.; Hézode, C.; Bronowicki, J.-P.; Loustaud-Ratti, V.; Gea, F.; Buti, M.; Olveira, A.; Banyai, T., et al., Journal of Hepatology 2016, 64, 292-300, http://doi.org/10.1016/j.jhep.2015.09.024
  93. Does epoetin beta still have a place in peginterferon alpha-2a plus ribavirin treatment strategies for chronic hepatitis c?, Veillon, P.; Fouchard-Hubert, I.; Larrey, D.; Dao, M. T.; D’alteroche, L.; Boyer-Darrigand, N.; Picard, N.; Le Guillou-Guillemette, H., et al., Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 2016, 36, 204-214, http://doi.org/10.1089/jir.2015.0131
  94. P-hydroxyphenyl-pyranoanthocyanins: An experimental and theoretical investigation of their acid-base properties and molecular interactions, Vallverdú-Queralt, A.; Biler, M.; Meudec, E.; Guernevé, C. L.; Vernhet, A.; Mazauric, J.-P.; Legras, J.-L.; Loonis, M., et al., International Journal of Molecular Sciences 2016, 17, http://doi.org/10.3390/ijms17111842
  95. Stabilizing and modulating color by copigmentation: Insights from theory and experiment, Trouillas, P.; Sancho-García, J. C.; De Freitas, V.; Gierschner, J.; Otyepka, M.; Dangles, O., Chemical Reviews 2016, 116, 4937-4982, http://doi.org/10.1021/acs.chemrev.5b00507
  96. Can an early diagnostic procedure of metformin-associated lactic acidosis in an emergency unit reduce mortality?, Sémely, D.; Bennett, E.; Vallejo, C.; Saint-Marcoux, F.; Merle, L.; Nouaille, Y.; Lachâtre, G.; Laroche, M.-L., Therapie 2016, 71, 605-612, http://doi.org/10.1016/j.therap.2016.05.006
  97. Practical information for therapeutic drug monitoring of the most common compounds, Saint-Marcoux, F.; Libert, F.; thérapeutique, g. S. t. p. d. l. S. f. d. p. e. d., Therapie 2016, 71, 405-434, http://doi.org/10.1016/j.therap.2016.01.007
  98. Flavonolignan 2,3-dehydroderivatives: Preparation, antiradical and cytoprotective activity, Pyszková, M.; Biler, M.; Biedermann, D.; Valentová, K.; Kuzma, M.; Vrba, J.; Ulrichová, J.; Sokolová, R., et al., Free Radical Biology & Medicine 2016, 90, 114-125, http://doi.org/10.1016/j.freeradbiomed.2015.11.014
  99. Overview of accessibility and quality of antiepileptic drugs in madagascar, Nizard, M.; Jost, J.; Tanamasoandro, R.; Andriambololona, R.; Megherbi, M.; Solofomalala, G. D.; Marquet, P.; Preux, P.-M., et al., Seizure 2016, 41, 134-140, http://doi.org/10.1016/j.seizure.2016.07.015
  100. Medicines and frailty in older people. Towards a new nosological entity: A pharmacological frailty?, Nessighaoui, H.; Géniaux, H.; Dantoine, T.; Laroche, M.-L., Therapie 2016, 71, 275-279, http://doi.org/10.1016/j.therap.2016.02.021
  101. Population pharmacokinetics of nevirapine in malaysian hiv patients: A non-parametric approach, Mustafa, S.; Yusuf, W. N. W.; Woillard, J. B.; Choon, T. S.; Hassan, N. B., European Journal of Clinical Pharmacology 2016, 72, 831-838, http://doi.org/10.1007/s00228-016-2049-6
  102. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: A systematic review, Morin, L.; Laroche, M.-L.; Texier, G.; Johnell, K., Journal of the American Medical Directors Association 2016, 17, 862.e1-9, http://doi.org/10.1016/j.jamda.2016.06.011
  103. Efficiency and safety of an early dose adjustment of ribavirin in patients infected with hepatitis c underexposed to the drug and treated with peginterferon ribavirin, Loustaud-Ratti, V.; Maynard, M.; Thevenon, S.; Pradat, P.; Rousseau, A.; Alain, S.; Deny, P.; Gagnieu, M.-C., et al., Therapeutic Drug Monitoring 2016, 38, 684-692, http://doi.org/10.1097/FTD.0000000000000332
  104. Hepatitis b and elders: An underestimated issue, Loustaud-Ratti, V.; Jacques, J.; Debette-Gratien, M.; Carrier, P., Hepatology Research: The Official Journal of the Japan Society of Hepatology 2016, 46, 22-28, http://doi.org/10.1111/hepr.12499
  105. Ribavirin: Past, present and future, Loustaud-Ratti, V.; Debette-Gratien, M.; Jacques, J.; Alain, S.; Marquet, P.; Sautereau, D.; Rousseau, A.; Carrier, P., World Journal of Hepatology 2016, 8, 123-130, http://doi.org/10.4254/wjh.v8.i2.123
  106. Pharmacovigilance in europe: Place of the pharmacovigilance risk assessment committee (prac) in organisation and decisional processes, Laroche, M.-L.; Batz, A.; Géniaux, H.; Féchant, C.; Merle, L.; Maison, P., Therapie 2016, 71, 161-169, http://doi.org/10.1016/j.therap.2016.02.008
  107. Impact of cyp2c19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections, Lamoureux, F.; Duflot, T.; Woillard, J.-B.; Metsu, D.; Pereira, T.; Compagnon, P.; Morisse-Pradier, H.; El Kholy, M., et al., International Journal of Antimicrobial Agents 2016, 47, 124-131, http://doi.org/10.1016/j.ijantimicag.2015.12.003
  108. A local structured training program with live pigs allows performing esd along the gastrointestinal tract with results close to those of japanese experts, Jacques, J.; Legros, R.; Charissoux, A.; Mesturoux, L.; Couquet, C.-Y.; Carrier, P.; Tabouret, T.; Valgueblasse, V., et al., Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2016, 48, 1457-1462, http://doi.org/10.1016/j.dld.2016.08.111
  109. Endoscopic mucosectomy of the normal mucosa facilitates exposure of the submucosal layer at the commencement of colorectal endoscopic submucosal dissection, Jacques, J.; Legros, R.; Carrier, P.; Geyl, S.; Loustaud-Ratti, V.; Sautereau, D.; Pioche, M., Endoscopy 2016, 48 Suppl 1, E213-214, http://doi.org/10.1055/s-0042-109054
  110. Hybridknife high-pressure glycerol jet injection for endoscopic submucosal dissection increases procedural ease and speed: A randomised study in pigs and a human case series, Jacques, J.; Kerever, S.; Carrier, P.; Couquet, C.-Y.; Debette-Gratien, M.; Tabouret, T.; Lepetit, H.; Geyl, S., et al., Surgical Endoscopy 2016, 30, 3152-3159, http://doi.org/10.1007/s00464-015-4554-6
  111. Hepatic encephalopathy, Jacques, J.; Carrier, P.; Debette-Gratien, M.; Sobesky, R.; Loustaud-Ratti, V., Presse Medicale (Paris, France: 1983) 2016, 45, 46-59, http://doi.org/10.1016/j.lpm.2015.02.021
  112. Rare hfe variants are the most frequent cause of hemochromatosis in non-c282y homozygous patients with hemochromatosis, Hamdi-Rozé, H.; Beaumont-Epinette, M.-P.; Ben Ali, Z.; Le Lan, C.; Loustaud-Ratti, V.; Causse, X.; Loreal, O.; Deugnier, Y., et al., American Journal of Hematology 2016, 91, 1202-1205, http://doi.org/10.1002/ajh.24535
  113. Peroral endoscopic pyloromyotomy accelerates gastric emptying in healthy pigs: Proof of concept, Geyl, S.; Legros, R.; Charissou, A.; Mesturoux, L.; Couquet, C.-Y.; Carrier, P.; Brayette, A.; El-Ouafi, Z., et al., Endoscopy International Open 2016, 4, E796-799, http://doi.org/10.1055/s-0042-108192
  114. Dimerization of quercetin, diels-alder vs. Radical-coupling approach: A joint thermodynamics, kinetics, and topological study, Fourré, I.; Di Meo, F.; Podloucká, P.; Otyepka, M.; Trouillas, P., Journal of Molecular Modeling 2016, 22, 190, http://doi.org/10.1007/s00894-016-3051-8
  115. Is it worth carrying out determination of n-butane in postmortem samples? A case report and a comprehensive review of the literature, El Balkhi, S.; Coutaz-Fluck, C.; Moreau, F.; Paraf, F.; Gaulier, J.-M., International Journal of Legal Medicine 2016, 130, 1223-1229, http://doi.org/10.1007/s00414-015-1260-9
  116. Quechers sample preparation prior to lc-ms/ms determination of opiates, amphetamines, and cocaine metabolites in whole blood, Dulaurent, S.; El Balkhi, S.; Poncelet, L.; Gaulier, J.-M.; Marquet, P.; Saint-Marcoux, F., Analytical and Bioanalytical Chemistry 2016, 408, 1467-1474, http://doi.org/10.1007/s00216-015-9248-3
  117. Different precore/core mutations of hepatitis b interact with, limit, or favor liver fibrosis severity, Ducancelle, A.; Pivert, A.; Bertrais, S.; Boursier, J.; Balan, V.; Veillon, P.; le Guillou-Guillemette, H.; Thibault, V., et al., Journal of Gastroenterology and Hepatology 2016, 31, 1750-1756, http://doi.org/10.1111/jgh.13338
  118. Hysterectomy for benign disease: Clinical practice guidelines from the french college of obstetrics and gynecology, Deffieux, X.; Rochambeau, B. d.; Chene, G.; Gauthier, T.; Huet, S.; Lamblin, G.; Agostini, A.; Marcelli, M., et al., European Journal of Obstetrics, Gynecology, and Reproductive Biology 2016, 202, 83-91, http://doi.org/10.1016/j.ejogrb.2016.04.006
  119. Heterozygous mutations in bmp6 pro-peptide lead to inappropriate hepcidin synthesis and moderate iron overload in humans, Daher, R.; Kannengiesser, C.; Houamel, D.; Lefebvre, T.; Bardou-Jacquet, E.; Ducrot, N.; de Kerguenec, C.; Jouanolle, A.-M., et al., Gastroenterology 2016, 150, 672-683.e4, http://doi.org/10.1053/j.gastro.2015.10.049
  120. Quality of serious adverse events reporting to academic sponsors of clinical trials: Far from optimal, Crépin, S.; Villeneuve, C.; Merle, L., Pharmacoepidemiology and Drug Safety 2016, 25, 719-724, http://doi.org/10.1002/pds.3982
  121. Q fever and pregnancy: Experience from the limoges regional university hospital, Coste Mazeau, P.; Hantz, S.; Eyraud, J.-L.; Donadel, L.; Lacorre, A.; Rogez, S.; Aubard, Y.; Gauthier, T., Archives of Gynecology and Obstetrics 2016, 294, 233-238, http://doi.org/10.1007/s00404-015-3958-9
  122. Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis c recurrence – the anrs cupilt study, Coilly, A.; Fougerou-Leurent, C.; de Ledinghen, V.; Houssel-Debry, P.; Duvoux, C.; Di Martino, V.; Radenne, S.; Kamar, N., et al., Journal of Hepatology 2016, 65, 711-718, http://doi.org/10.1016/j.jhep.2016.05.039
  123. Association of the oprm1 and comt genes’ polymorphisms with the efficacy of morphine in tunisian cancer patients: Impact of the high genetic heterogeneity in tunisia?, Chatti, I.; Creveaux, I.; Woillard, J.-B.; Langlais, S.; Amara, A.; Ben Fatma, L.; Saad, A.; Gribaa, M., et al., Therapie 2016, 71, 507-513, http://doi.org/10.1016/j.therap.2016.04.004
  124. Anti-hepatitis c virus drugs and kidney, Carrier, P.; Essig, M.; Debette-Gratien, M.; Sautereau, D.; Rousseau, A.; Marquet, P.; Jacques, J.; Loustaud-Ratti, V., World Journal of Hepatology 2016, 8, 1343-1353, http://doi.org/10.4254/wjh.v8.i32.1343
  125. Liver illness and psychiatric patients, Carrier, P.; Debette-Gratien, M.; Girard, M.; Jacques, J.; Nubukpo, P.; Loustaud-Ratti, V., Hepatitis Monthly 2016, 16, e41564, http://doi.org/10.5812/hepatmon.41564
  126. A pseudoencephalitis presentation of a pediatric non-intentional intoxication, Bréhin, C.; Cessans, C.; Monchaud, C.; Lavit, M.; Majorel, C.; Claudet, I., European journal of paediatric neurology: EJPN: official journal of the European Paediatric Neurology Society 2016, 20, 418-420, http://doi.org/10.1016/j.ejpn.2016.02.010
  127. Consequences of conformational flexibility in hydrogen-bond-driven self-assembly processes, Berrocal, J. A.; Di Meo, F.; García-Iglesias, M.; Gosens, R. P. J.; Meijer, E. W.; Linares, M.; Palmans, A. R. A., Chemical Communications 2016, 52 (72), 10870-10873, http://doi.org/10.1039/C6CC05593A
  128. Pharmacovigilance: The new challenges, Bagheri, H.; Laroche, M.-L.; Montastruc, J.-L., Therapie 2016, 71, 121-122, http://doi.org/10.1016/j.therap.2016.02.019
  129. Interferon-free antiviral treatment in b-cell lymphoproliferative disorders associated with hepatitis c virus infection, Arcaini, L.; Besson, C.; Frigeni, M.; Fontaine, H.; Goldaniga, M.; Casato, M.; Visentini, M.; Torres, H. A., et al., Blood 2016, 128, 2527-2532, http://doi.org/10.1182/blood-2016-05-714667
  130. Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis c genotype 4 infection, Abergel, A.; Metivier, S.; Samuel, D.; Jiang, D.; Kersey, K.; Pang, P. S.; Svarovskaia, E.; Knox, S. J., et al., Hepatology (Baltimore, Md.) 2016, 64, 1049-1056, http://doi.org/10.1002/hep.28706
  131. Ledipasvir-sofosbuvir in patients with hepatitis c virus genotype 5 infection: An open-label, multicentre, single-arm, phase 2 study, Abergel, A.; Asselah, T.; Metivier, S.; Kersey, K.; Jiang, D.; Mo, H.; Pang, P. S.; Samuel, D., et al., The Lancet. Infectious Diseases 2016, 16, 459-464, http://doi.org/10.1016/S1473-3099(15)00529-0
  132. Some thoughts on the links between lc-ms/ms and therapeutic drug monitoring, Saint-Marcoux, F., Annales De Biologie Clinique 2015, 73, 49-53, http://doi.org/10.1684/abc.2014.1008
  133. Clinical characteristics and outcomes of childhood-onset anca-associated vasculitis: A french nationwide study, Sacri, A.-S.; Chambaraud, T.; Ranchin, B.; Florkin, B.; Sée, H.; Decramer, S.; Flodrops, H.; Ulinski, T., et al., Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association – European Renal Association 2015, 30 Suppl 1, i104-112, http://doi.org/10.1093/ndt/gfv011
  134. Igm peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events, Rizzo, D.; Chauzeix, J.; Trimoreau, F.; Woillard, J. B.; Genevieve, F.; Bouvier, A.; Labrousse, J.; Poli, C., et al., Leukemia 2015, 29, 337-345, http://doi.org/10.1038/leu.2014.198
  135. Therapeutic management and evolution of chronic hepatitis b: Does hiv still have an impact? The epib 2012 study, Piroth, L.; Pol, S.; Miailhes, P.; Lacombe, K.; Lopes, A.; Fillion, A.; Loustaud-Ratti, V.; Borsa-Lebas, F., et al., Liver International: Official Journal of the International Association for the Study of the Liver 2015, 35, 1950-1958, http://doi.org/10.1111/liv.12777
  136. Frailty and pain: Two related conditions, Nessighaoui, H.; Lilamand, M.; Patel, K. V.; Vellas, B.; Laroche, M. L.; Dantoine, T.; Cesari, M., The Journal of Frailty & Aging 2015, 4, 144-148, http://doi.org/10.14283/jfa.2015.53
  137. Potentially inappropriate drug use in older people: A nationwide comparison of different explicit criteria for population-based estimates, Morin, L.; Fastbom, J.; Laroche, M.-L.; Johnell, K., British Journal of Clinical Pharmacology 2015, 80, 315-324, http://doi.org/10.1111/bcp.12615
  138. Ex vivo model of congenital cytomegalovirus infection and new combination therapies, Morère, L.; Andouard, D.; Labrousse, F.; Saade, F.; Calliste, C.-A.; Cotin, S.; Aubard, Y.; Rawlinson, W. D., et al., Placenta 2015, 36, 41-47, http://doi.org/10.1016/j.placenta.2014.11.003
  139. Translational research: Precision medicine, personalized medicine, targeted therapies: Marketing or science?, Marquet, P.; Longeray, P.-H.; Barlesi, F.; XXX:, p. o. r. t. N. o. G.; Ameye, V.; Augé, P.; Cazeneuve, B.; Chatelut, E., et al., Therapie 2015, 70, 1-19, http://doi.org/10.2515/therapie/2014231
  140. How to avoid the complications associated with hysterectomy: Place of subtotal hysterectomy, prevention of venous thromboembolism risk and preoperative treatment: Guidelines, Marcelli, M.; Gauthier, T.; Chêne, G.; Lamblin, G.; Agostini, A.; (CNGOF), F. C. o. O. a. G., Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2015, 44, 1206-1218, http://doi.org/10.1016/j.jgyn.2015.09.015
  141. Egfr decrease during antiviral c therapy with first generation protease inhibitors: A clinical significance?, Loustaud-Ratti, V.; Rousseau, A.; Carrier, P.; Vong, C.; Chambaraud, T.; Jacques, J.; Debette-Gratien, M.; Sautereau, D., et al., Liver International: Official Journal of the International Association for the Study of the Liver 2015, 35, 71-78, http://doi.org/10.1111/liv.12631
  142. Adverse reactions to radiopharmaceuticals in france: Analysis of the national pharmacovigilance database, Laroche, M.-L.; Quelven, I.; Mazère, J.; Merle, L., The Annals of Pharmacotherapy 2015, 49, 39-47, http://doi.org/10.1177/1060028014558153
  143. Adverse drug reactions reported with cholinesterase inhibitors: An analysis of 16 years of individual case safety reports from vigibase, Kröger, E.; Mouls, M.; Wilchesky, M.; Berkers, M.; Carmichael, P.-H.; van Marum, R.; Souverein, P.; Egberts, T., et al., The Annals of Pharmacotherapy 2015, 49, 1197-1206, http://doi.org/10.1177/1060028015602274
  144. Impact of surgical case volume on the accuracy of preoperative staging and compliance with the guidelines for the management of endometrial cancer, Koskas, M.; Ouldamer, L.; Bourdel, N.; Gauthier, T.; Brun, J.-L.; Huchon, C., Anticancer Research 2015, 35, 2887-2891,
  145. Adherence to online monitoring of patient-reported outcomes by patients with chronic inflammatory diseases: A feasibility study, Jamilloux, Y.; Sarabi, M.; Kérever, S.; Boussely, N.; le Sidaner, A.; Valgueblasse, V.; Carrier, P.; Loustaud-Ratti, V., et al., Lupus 2015, 24, 1429-1436, http://doi.org/10.1177/0961203315585814
  146. High-pressure injection of glycerol with hybridknife for esd is feasible and increases the ease and speed of the procedure: An in vivo study in pigs and first use in human, Jacques, J.; Sautereau, D.; Carrier, P.; Couquet, C.-Y.; Debette-Gratien, M.; Le-Sidaner, A.; Tabouret, T.; Valgueblasse, V., et al., Surgical Endoscopy 2015, 29, 3382-3385, http://doi.org/10.1007/s00464-015-4072-6
  147. Proctitis cystica profunda diagnosed by endoscopic submucosal dissection: Use of a therapeutic procedure for diagnosis, Jacques, J.; Mesturoux, L.; Carrier, P.; Tabouret, T.; Loustaud-Ratti, V.; Sautereau, D.; Legros, R., Endoscopy 2015, 47 Suppl 1 UCTN, E255-256, http://doi.org/10.1055/s-0034-1392026
  148. Salvage hemostasis by scope compression during rectal endoscopic submucosal dissection, Jacques, J.; Legros, R.; Carrier, P.; Mesturoux, L.; Geyl, S.; Loustaud-Ratti, V.; Sautereau, D., Endoscopy 2015, 47 Suppl 1 UCTN, E22-23, http://doi.org/10.1055/s-0034-1390724
  149. A combination of the clip-with-line method and the tunnel technique during esophageal endoscopic submucosal dissection: A technical solution?, Jacques, J.; Geyl, S.; Carrier, P.; Tabouret, T.; Loustaud-Ratti, V.; Sautereau, D.; Legros, R., Endoscopy 2015, 47 Suppl 1 UCTN, E307-308, http://doi.org/10.1055/s-0034-1392240
  150. Human rhinovirus infection and cirrhosis: A potential fatal complication, Jacques, J.; Carrier, P.; Legros, R.; Loustaud-Ratti, V., Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2015, 47, 175-176, http://doi.org/10.1016/j.dld.2014.09.018
  151. Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients, Hareedy, M. S.; El Desoky, E. S.; Woillard, J.-B.; Thabet, R. H.; Ali, A. M.; Marquet, P.; Picard, N., Pharmacogenomics 2015, 16, 1119-1134, http://doi.org/10.2217/PGS.15.62
  152. Hysterectomy for benign gynaecological disease: Surgical approach, vaginal suture method and morcellation: Guidelines, Gauthier, T.; Huet, S.; Marcelli, M.; Lamblin, G.; Chêne, G.; (CNGOF), F. C. o. O. a. G., Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2015, 44, 1168-1182, http://doi.org/10.1016/j.jgyn.2015.09.032
  153. Ugt1a1 genotype and irinotecan therapy: General review and implementation in routine practice, Etienne-Grimaldi, M.-C.; Boyer, J.-C.; Thomas, F.; Quaranta, S.; Picard, N.; Loriot, M.-A.; Narjoz, C.; Poncet, D., et al., Fundamental & Clinical Pharmacology 2015, 29, 219-237, http://doi.org/10.1111/fcp.12117
  154. Therapeutic drug monitoring of clozapine, Djerada, Z.; Daviet, F.; Llorca, P.-M.; Eschalier, A.; Saint-Marcoux, F.; Bentué-Ferrer, D.; Libert, F., Therapie 2015, http://doi.org/10.2515/therapie/2015041
  155. Unraveling the performance of dispersion-corrected functionals for the accurate description of weakly bound natural polyphenols, Di Meo, F.; Bayach, I.; Trouillas, P.; Sancho-García, J.-C., Journal of Molecular Modeling 2015, 21, 291, http://doi.org/10.1007/s00894-015-2838-3
  156. Hysterectomy for benign pathology: Guidelines for clinical practice, Deffieux, X.; de Rochambeau, B.; Chêne, G.; Gauthier, T.; Huet, S.; Lamblin, G.; Agostini, A.; Marcelli, M., et al., Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2015, 44, 1219-1227, http://doi.org/10.1016/j.jgyn.2015.09.027
  157. Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice, Danigo, A.; Nasser, M.; Bessaguet, F.; Javellaud, J.; Oudart, N.; Achard, J.-M.; Demiot, C., Cardiovascular Diabetology 2015, 14, 26, http://doi.org/10.1186/s12933-015-0185-4
  158. Multicenter experience with boceprevir or telaprevir to treat hepatitis c recurrence after liver transplantation: When present becomes past, what lessons for future?, Coilly, A.; Dumortier, J.; Botta-Fridlund, D.; Latournerie, M.; Leroy, V.; Pageaux, G.-P.; Agostini, H.; Giostra, E., et al., PloS One 2015, 10, e0138091, http://doi.org/10.1371/journal.pone.0138091
  159. Urinary, infectious and digestive adverse events related to benign hysterectomy and the associated surgery on the fallopian tube: Guidelines, Chêne, G.; Lamblin, G.; Marcelli, M.; Huet, S.; Gauthier, T.; (CNGOF), F. C. o. O. a. G., Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2015, 44, 1183-1205, http://doi.org/10.1016/j.jgyn.2015.09.031
  160. Drug-induced pancreatitis. A review of french spontaneous reports, Chebane, L.; Bagheri, H.; Hillaire-Buys, D.; Géniaux, H.; Yahioui, N.; Laroche, M.-L.; Cottin, J.; Spreux, A., et al., La Revue De Medecine Interne 2015, 36, 573-578, http://doi.org/10.1016/j.revmed.2015.04.012
  161. Hcv-associated b-cell non-hodgkin lymphomas and new direct antiviral agents, Carrier, P.; Jaccard, A.; Jacques, J.; Tabouret, T.; Debette-Gratien, M.; Abraham, J.; Mesturoux, L.; Marquet, P., et al., Liver International: Official Journal of the International Association for the Study of the Liver 2015, 35, 2222-2227, http://doi.org/10.1111/liv.12897
  162. Ledipasvir-sofosbuvir with or without ribavirin to treat patients with hcv genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: A randomised, double-blind, phase 2 trial (sirius), Bourlière, M.; Bronowicki, J.-P.; de Ledinghen, V.; Hézode, C.; Zoulim, F.; Mathurin, P.; Tran, A.; Larrey, D. G., et al., The Lancet. Infectious Diseases 2015, 15, 397-404, http://doi.org/10.1016/S1473-3099(15)70050-2
  163. Indomethacin, amiloride, or eplerenone for treating hypokalemia in gitelman syndrome, Blanchard, A.; Vargas-Poussou, R.; Vallet, M.; Caumont-Prim, A.; Allard, J.; Desport, E.; Dubourg, L.; Monge, M., et al., Journal of the American Society of Nephrology: JASN 2015, 26, 468-475, http://doi.org/10.1681/ASN.2014030293
  164. Oligostilbenoids from the heartwood of n. Heimii: Role of non-covalent association in their biogenesis, Bayach, I.; Manshoor, N.; Sancho-García, J. C.; Choudhary, M. I.; Trouillas, P.; Weber, J.-F. F., Chemistry, an Asian Journal 2015, 10, 198-211, http://doi.org/10.1002/asia.201402673
  165. Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis c cirrhotic patients who failed a previous interferon based regimen – the anrs co20-cupic study, Bailly, F.; Virlogeux, V.; Dufour, C.; Pradat, P.; Hézode, C.; Larrey, D.; Alric, L.; Samuel, D., et al., Clinics and Research in Hepatology and Gastroenterology 2015, 39, 443-450, http://doi.org/10.1016/j.clinre.2014.12.007
  166. Drug shortage may have serious outcome: The french exemple of phenytoine, Auffret, M.; Tyvaert, L.; Laroche, M.-L.; Godet, B.; Peyron, R.; Guy, C.; Géniaux, H.; Pécriaux, C., et al., Therapie 2015, 70, 377-380, http://doi.org/10.2515/therapie/2015018